Sort by
Items per page

Send to

Choose Destination

Search results

Items: 16


Pre-Operative Delta-MELD is an Independent Predictor of Higher Mortality following Liver Transplantation.

Cholankeril G, Li AA, Dennis BB, Gadiparthi C, Kim D, Toll AE, Maliakkal BJ, Satapathy SK, Nair S, Ahmed A.

Sci Rep. 2019 Jun 5;9(1):8312. doi: 10.1038/s41598-019-44814-y.


Hepatocellular carcinoma is leading in cancer-related disease burden among hospitalized baby boomers.

Gadiparthi C, Yoo ER, Are VS, Charilaou P, Kim D, Cholankeril G, Pitchumoni C, Ahmed A.

Ann Hepatol. 2019 May 21. pii: S1665-2681(19)30343-6. doi: 10.1016/j.aohep.2019.04.014. [Epub ahead of print]


Nonalcoholic Fatty Liver Disease: Epidemiology, Liver Transplantation Trends and Outcomes, and Risk of Recurrent Disease in the Graft.

Liu A, Galoosian A, Kaswala D, Li AA, Gadiparthi C, Cholankeril G, Kim D, Ahmed A.

J Clin Transl Hepatol. 2018 Dec 28;6(4):420-424. doi: 10.14218/JCTH.2018.00010. Epub 2018 Jul 28. Review.


Temporal Trends Associated With the Rise in Alcoholic Liver Disease-related Liver Transplantation in the United States.

Cholankeril G, Gadiparthi C, Yoo ER, Dennis BB, Li AA, Hu M, Wong K, Kim D, Ahmed A.

Transplantation. 2019 Jan;103(1):131-139. doi: 10.1097/TP.0000000000002471.


Changing Trends in Etiology-Based and Ethnicity-Based Annual Mortality Rates of Cirrhosis and Hepatocellular Carcinoma in the United States.

Kim D, Li AA, Perumpail BJ, Gadiparthi C, Kim W, Cholankeril G, Glenn JS, Harrison SA, Younossi ZM, Ahmed A.

Hepatology. 2019 Mar;69(3):1064-1074. doi: 10.1002/hep.30161. Epub 2019 Feb 11.


Changing Trends in Etiology-Based Annual Mortality From Chronic Liver Disease, From 2007 Through 2016.

Kim D, Li AA, Gadiparthi C, Khan MA, Cholankeril G, Glenn JS, Ahmed A.

Gastroenterology. 2018 Oct;155(4):1154-1163.e3. doi: 10.1053/j.gastro.2018.07.008. Epub 2018 Sep 1.


Role of Cholecystectomy After Endoscopic Sphincterotomy in the Management of Choledocholithiasis in High-risk Patients: A Systematic Review and Meta-Analysis.

Khan MA, Khan Z, Tombazzi CR, Gadiparthi C, Lee W, Wilcox CM.

J Clin Gastroenterol. 2018 Aug;52(7):579-589. doi: 10.1097/MCG.0000000000001076.


The Role of Cannabinoids in the Setting of Cirrhosis.

Dibba P, Li AA, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 Jun 9;5(2). pii: E52. doi: 10.3390/medicines5020052. Review.


Mechanistic Potential and Therapeutic Implications of Cannabinoids in Nonalcoholic Fatty Liver Disease.

Dibba P, Li A, Cholankeril G, Iqbal U, Gadiparthi C, Khan MA, Kim D, Ahmed A.

Medicines (Basel). 2018 May 28;5(2). pii: E47. doi: 10.3390/medicines5020047. Review.


Expanding Donor Pool for Liver Transplantation by Utilizing Hepatitis C Virus-Infected Donors for Uninfected Recipients.

Cholankeril G, Gadiparthi C, Kim D, Ahmed A.

Hepatology. 2018 Aug;68(2):792-793. doi: 10.1002/hep.30043. No abstract available.


Waitlist Outcomes in Liver Transplant Candidates with High MELD and Severe Hepatic Encephalopathy.

Gadiparthi C, Cholankeril G, Yoo ER, Hu M, Wong RJ, Ahmed A.

Dig Dis Sci. 2018 Jun;63(6):1647-1653. doi: 10.1007/s10620-018-5032-5. Epub 2018 Apr 2.


Reactivation of hepatitis B after liver transplantation: Current knowledge, molecular mechanisms and implications in management.

Chauhan R, Lingala S, Gadiparthi C, Lahiri N, Mohanty SR, Wu J, Michalak TI, Satapathy SK.

World J Hepatol. 2018 Mar 27;10(3):352-370. doi: 10.4254/wjh.v10.i3.352. Review.


Use of direct-acting antiviral agents in hepatitis C virus-infected liver transplant candidates.

Gadiparthi C, Cholankeril G, Perumpail BJ, Yoo ER, Satapathy SK, Nair S, Ahmed A.

World J Gastroenterol. 2018 Jan 21;24(3):315-322. doi: 10.3748/wjg.v24.i3.315. Review.


Gastrointestinal and Hepatic Disease in the Inflammatory Myopathies.

Gadiparthi C, Hans A, Potts K, Ismail MK.

Rheum Dis Clin North Am. 2018 Feb;44(1):113-129. doi: 10.1016/j.rdc.2017.09.006. Review.


Catastrophic left main coronary artery occlusion following diagnostic coronary angiography: salvage by emergency left main coronary artery stenting.

Abdel-Karim AR, Gadiparthi C, Banerjee S, Brilakis ES.

Acute Card Care. 2011 Sep;13(3):170-3. doi: 10.3109/17482941.2011.567276. Epub 2011 Apr 25.


A randomized controlled trial of a paclitaxel-eluting stent versus a similar bare-metal stent in saphenous vein graft lesions the SOS (Stenting of Saphenous Vein Grafts) trial.

Brilakis ES, Lichtenwalter C, de Lemos JA, Roesle M, Obel O, Haagen D, Saeed B, Gadiparthi C, Bissett JK, Sachdeva R, Voudris VV, Karyofillis P, Kar B, Rossen J, Fasseas P, Berger P, Banerjee S.

J Am Coll Cardiol. 2009 Mar 17;53(11):919-28. doi: 10.1016/j.jacc.2008.11.029.

Supplemental Content

Loading ...
Support Center